STING1 and colorectal carcinoma: Since our results showed that higher PD-L1 levels were elicited by MSC-sTRAIL, we evaluated whether MST-sTRAIL enhanced the therapeutic efficacy of radiotherapy and immunotherapy in STING-deficient CRC cells.